Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Rank in Stocks #5454
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Share Price
$93.80
Last synced: 2025-04-28
Market Cap
$2.68B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Aerovate Therapeutics, Inc. (AVTE)

Category

Dividend history for Aerovate Therapeutics, Inc. (AVTE)
Aerovate Therapeutics, Inc. (stock symbol: AVTE) made a total of 1 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $2.40
Dividend yield (TTM) : 0
Dividend payments for Aerovate Therapeutics, Inc. (AVTE) from 2025 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
2026 (TTM) $2.40 0.00%
2025 $2.40 0.00%
List of all dividend payments
Year Dividend Change
2026 (TTM) $84.00 0.00%
2025 $84.00 0.00%
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
0.00%
US
0.00%
NL
0.00%
US
64.00%
AU
0.00%
CH